1.Ventral inlay buccal mucosal graft urethroplasty: A novel surgical technique for the management of urethral stricture disease.
Robert Caleb KOVELL ; Ryan Patrick TERLECKI
Korean Journal of Urology 2015;56(2):164-167
To describe the novel technique of ventral inlay substitution urethroplasty for the management of male anterior urethral stricture disease. A 58-year-old gentleman with multifocal bulbar stricture disease measuring 7 cm in length was treated using a ventral inlay substitution urethroplasty. A dorsal urethrotomy was created, and the ventral urethral plated was incised. The edges of the urethral plate were mobilized without violation of the ventral corpus spongiosum. A buccal mucosa graft was harvested and affixed as a ventral inlay to augment the caliber of the urethra. The dorsal urethrotomy was closed over a foley catheter. No intraoperative or postoperative complications occurred. Postoperative imaging demonstrated a widely patent urethra. After three years of follow-up, the patient continues to do well with no voiding complaints and low postvoid residuals. Ventral inlay substitution urethroplasty appears to be a safe and feasible technique for the management of bulbar urethral strictures.
Cystoscopy/methods
;
Humans
;
Male
;
Middle Aged
;
Mouth Mucosa/*transplantation
;
Urethra/surgery
;
Urethral Stricture/diagnosis/*surgery
;
Urologic Surgical Procedures, Male/methods
2.Conversion and Data Quality Assessment of Electronic Health Record Data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research.
Dukyong YOON ; Eun Kyoung AHN ; Man Young PARK ; Soo Yeon CHO ; Patrick RYAN ; Martijn J SCHUEMIE ; Dahye SHIN ; Hojun PARK ; Rae Woong PARK
Healthcare Informatics Research 2016;22(1):54-58
OBJECTIVES: A distributed research network (DRN) has the advantages of improved statistical power, and it can reveal more significant relationships by increasing sample size. However, differences in data structure constitute a major barrier to integrating data among DRN partners. We describe our experience converting Electronic Health Records (EHR) to the Observational Health Data Sciences and Informatics (OHDSI) Common Data Model (CDM). METHODS: We transformed the EHR of a hospital into Observational Medical Outcomes Partnership (OMOP) CDM ver. 4.0 used in OHDSI. All EHR codes were mapped and converted into the standard vocabulary of the CDM. All data required by the CDM were extracted, transformed, and loaded (ETL) into the CDM structure. To validate and improve the quality of the transformed dataset, the open-source data characterization program ACHILLES was run on the converted data. RESULTS: Patient, drug, condition, procedure, and visit data from 2.07 million patients who visited the subject hospital from July 1994 to November 2014 were transformed into the CDM. The transformed dataset was named the AUSOM. ACHILLES revealed 36 errors and 13 warnings in the AUSOM. We reviewed and corrected 28 errors. The summarized results of the AUSOM processed with ACHILLES are available at http://ami.ajou.ac.kr:8080/. CONCLUSIONS: We successfully converted our EHRs to a CDM and were able to participate as a data partner in an international DRN. Converting local records in this manner will provide various opportunities for researchers and data holders.
Clinical Coding
;
Data Accuracy*
;
Dataset
;
Electronic Health Records*
;
Epidemiologic Methods
;
Hospitals, Teaching*
;
Humans
;
Informatics
;
Sample Size
;
Vocabulary
3.Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
Seng Chan YOU ; Sungjae JUNG ; Joel N SWERDEL ; Patrick B RYAN ; Martijn J SCHUEMIE ; Marc A SUCHARD ; Seongwon LEE ; Jaehyeong CHO ; George HRIPCSAK ; Rae Woong PARK ; Sungha PARK
Korean Circulation Journal 2020;50(1):52-68
BACKGROUND AND OBJECTIVES: 2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited. We aimed to compare the effectiveness of first-line anti-hypertensive treatment combining 2 out of the following classes: angiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blocker (A), calcium channel blocker (C), and thiazide-type diuretics (D).METHODS: Treatment-naïve hypertensive adults without cardiovascular disease (CVD) who initiated dual anti-hypertensive medications were identified in 5 databases from US and Korea. The patients were matched for each comparison set by large-scale propensity score matching. Primary endpoint was all-cause mortality. Myocardial infarction, heart failure, stroke, and major adverse cardiac and cerebrovascular events as a composite outcome comprised the secondary measure.RESULTS: A total of 987,983 patients met the eligibility criteria. After matching, 222,686, 32,344, and 38,513 patients were allocated to A+C vs. A+D, C+D vs. A+C, and C+D vs. A+D comparison, respectively. There was no significant difference in the mortality during total of 1,806,077 person-years: A+C vs. A+D (hazard ratio [HR], 1.08; 95% confidence interval [CI], 0.97−1.20; p=0.127), C+D vs. A+C (HR, 0.93; 95% CI, 0.87−1.01; p=0.067), and C+D vs. A+D (HR, 1.18; 95% CI, 0.95−1.47; p=0.104). A+C was associated with a slightly higher risk of heart failure (HR, 1.09; 95% CI, 1.01−1.18; p=0.040) and stroke (HR, 1.08; 95% CI, 1.01−1.17; p=0.040) than A+D.CONCLUSIONS: There was no significant difference in mortality among A+C, A+D, and C+D combination treatment in patients without previous CVD. This finding was consistent across multi-national heterogeneous cohorts in real-world practice.
Adult
;
Angiotensin Receptor Antagonists
;
Antihypertensive Agents
;
Calcium Channel Blockers
;
Calcium Channels
;
Cardiovascular Diseases
;
Cohort Studies
;
Diuretics
;
Heart Failure
;
Humans
;
Hypertension
;
Korea
;
Mortality
;
Myocardial Infarction
;
Propensity Score
;
Stroke
4.Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
Seng Chan YOU ; Sungjae JUNG ; Joel N SWERDEL ; Patrick B RYAN ; Martijn J SCHUEMIE ; Marc A SUCHARD ; Seongwon LEE ; Jaehyeong CHO ; George HRIPCSAK ; Rae Woong PARK ; Sungha PARK
Korean Circulation Journal 2020;50(1):52-68
BACKGROUND AND OBJECTIVES:
2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited. We aimed to compare the effectiveness of first-line anti-hypertensive treatment combining 2 out of the following classes: angiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blocker (A), calcium channel blocker (C), and thiazide-type diuretics (D).
METHODS:
Treatment-naïve hypertensive adults without cardiovascular disease (CVD) who initiated dual anti-hypertensive medications were identified in 5 databases from US and Korea. The patients were matched for each comparison set by large-scale propensity score matching. Primary endpoint was all-cause mortality. Myocardial infarction, heart failure, stroke, and major adverse cardiac and cerebrovascular events as a composite outcome comprised the secondary measure.
RESULTS:
A total of 987,983 patients met the eligibility criteria. After matching, 222,686, 32,344, and 38,513 patients were allocated to A+C vs. A+D, C+D vs. A+C, and C+D vs. A+D comparison, respectively. There was no significant difference in the mortality during total of 1,806,077 person-years: A+C vs. A+D (hazard ratio [HR], 1.08; 95% confidence interval [CI], 0.97−1.20; p=0.127), C+D vs. A+C (HR, 0.93; 95% CI, 0.87−1.01; p=0.067), and C+D vs. A+D (HR, 1.18; 95% CI, 0.95−1.47; p=0.104). A+C was associated with a slightly higher risk of heart failure (HR, 1.09; 95% CI, 1.01−1.18; p=0.040) and stroke (HR, 1.08; 95% CI, 1.01−1.17; p=0.040) than A+D.
CONCLUSIONS
There was no significant difference in mortality among A+C, A+D, and C+D combination treatment in patients without previous CVD. This finding was consistent across multi-national heterogeneous cohorts in real-world practice.
5.Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children
Anshu MAHESHWARI ; Zhaoping HE ; Melissa Nicole WEIDNER ; Patrick LIN ; Ryan BOBER ; Fernando J. DEL ROSARIO
Pediatric Gastroenterology, Hepatology & Nutrition 2021;24(2):218-229
Purpose:
Serological tests of tissue transglutaminase (TTG) and deamidated gliadin (DGP) antibodies for celiac disease diagnosis show conflicting correlation with histology in young children and in type 1 diabetes mellitus (T1DM). Tests' ability to predict histology and cutoff values based on age and T1DM was evaluated.
Methods:
A retrospective study of children who had celiac serological tests between 6/1/2002 and 12/31/2014 at a pediatric hospital.
Results:
TTG IgA displayed similar results in predicting histology between <4.0 and ≥4.0 years age groups with sensitivity 98% and 93%, and specificity 88% and 86%, respectively. In children <4.0 years old, sensitivity for DGP antibodies was 100% and specificity 94%; in ≥4.0 years age groups, sensitivity was 60%, 88% for DGP IgA and IgG and specificity 95%, 96%, respectively. TTG IgA had low specificity in patients with T1DM compared with non-T1DM, 42% vs. 91%. Positive TTG IgA with normal histology was associated with higher T1DM prevalence at 36% compared with negative tests at 4%. Finally, the TTG IgA cutoff value was higher in T1DM at 36 vs. 16.3 units in non-T1DM. DGP IgG cutoff showed similar values between age groups; TTG IgA and DGP IgA cutoffs were lower in <4.0 years at 8.3 and 11.9 units than ≥4.0 years at 23.4 and 19.9, respectively.
Conclusion
TTG IgA is sufficient for the <4.0 years age group and DGP antibodies had no advantage over TTG IgA in older children. The cutoff value to determine a positive TTG IgA should be higher for children with T1DM.
6.Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children
Anshu MAHESHWARI ; Zhaoping HE ; Melissa Nicole WEIDNER ; Patrick LIN ; Ryan BOBER ; Fernando J. DEL ROSARIO
Pediatric Gastroenterology, Hepatology & Nutrition 2021;24(2):218-229
Purpose:
Serological tests of tissue transglutaminase (TTG) and deamidated gliadin (DGP) antibodies for celiac disease diagnosis show conflicting correlation with histology in young children and in type 1 diabetes mellitus (T1DM). Tests' ability to predict histology and cutoff values based on age and T1DM was evaluated.
Methods:
A retrospective study of children who had celiac serological tests between 6/1/2002 and 12/31/2014 at a pediatric hospital.
Results:
TTG IgA displayed similar results in predicting histology between <4.0 and ≥4.0 years age groups with sensitivity 98% and 93%, and specificity 88% and 86%, respectively. In children <4.0 years old, sensitivity for DGP antibodies was 100% and specificity 94%; in ≥4.0 years age groups, sensitivity was 60%, 88% for DGP IgA and IgG and specificity 95%, 96%, respectively. TTG IgA had low specificity in patients with T1DM compared with non-T1DM, 42% vs. 91%. Positive TTG IgA with normal histology was associated with higher T1DM prevalence at 36% compared with negative tests at 4%. Finally, the TTG IgA cutoff value was higher in T1DM at 36 vs. 16.3 units in non-T1DM. DGP IgG cutoff showed similar values between age groups; TTG IgA and DGP IgA cutoffs were lower in <4.0 years at 8.3 and 11.9 units than ≥4.0 years at 23.4 and 19.9, respectively.
Conclusion
TTG IgA is sufficient for the <4.0 years age group and DGP antibodies had no advantage over TTG IgA in older children. The cutoff value to determine a positive TTG IgA should be higher for children with T1DM.
7.The Efficacy of Physical Therapy to Alleviate Symptomatic Thoracic Radiculopathy: A Systematic Review and Meta-Narrative Analysis
Karson A MOSTERT ; Jacob PERERA ; Jennifer Dens HIGANO ; Patrick T DAVIS ; Ryan J BUUS ; Danielle GERBERI ; James MEILING ; Cara PRIDEAUX
Annals of Rehabilitation Medicine 2024;48(2):105-114
To evaluate the efficacy of physical therapy (PT) to alleviate symptomatic thoracic radiculopathy (TR) without the use of invasive procedures. Database search was conducted by an experienced medical librarian from inception until January 27, 2023, in EBSCO CINAHL with Full Text, Ovid Cochrane Central Register of Controlled Trials, Ovid Embase, Ovid MEDLINE, Scopus, and Web of Science Core Collection. Inclusion criteria included studies that involved adult patients (age≥18) who had a magnetic resonance imaging-confirmed TR and underwent a structured, supervised PT program of any length. All types of studies were included. Study quality and risk of bias were assessed using the National Heart, Lung, and Blood Institute (NHLBI) Study Quality of Assessment Tool. Certainty in evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. A meta-analysis was not performed. A total of 1,491 studies were screened and 7 studies met inclusion criteria, 5 case studies and 2 cohort studies. All studies showed improvement or resolution of the TR with PT. Quantitative improvements were not noted in most studies and PT regimens were sparsely described. Overall quality assessment demonstrated 3 studies had “good,” 1 “fair,” and 3 “poor” quality evidence. Certainty of evidence was “low” due to risk of bias. A dedicated PT program may help to alleviate symptomatic TR; however due to limited evidence, risk of bias, and low certainty in evidence, the data is too weak to support a definite conclusion.
8.A makeshift blue light filter for endoscopic identification of traumatic cerebrospinal fluid leak using fluorescein.
Bianca Denise E. EDORA ; Ryan U. CHUA ; Patrick Joseph L. ESTOLANO
Philippine Journal of Otolaryngology Head and Neck Surgery 2022;37(2):46-49
Objective:
To describe a makeshift blue light filter for endoscopic visualization of a traumatic cerebrospinal fluid leak repair using intrathecal fluorescein and its application in one patient.
Methods:
Study Design:Surgical Instrumentation
Setting:Tertiary Government Training Hospital
Patient:One
Results:
Intra-operative endoscopic identification of fistulae sites was achieved using intrathecal injection of fluorescein that fluoresced using our makeshift blue light filter in a 43-year-old man who presented with a 3-month history of rhinorrhea due to skull base fractures along with multiple facial and upper extremity fractures he sustained after a fall from a standing height of 6 feet. He underwent transnasal endoscopic repair of cerebrospinal fluid fistulae in the planum sphenoidale, clivus and sellar floor. Post-operatively, there was complete resolution of rhinorrhea with no complications noted.
Conclusion
Our makeshift blue light filter made from readily available materials may be useful for endoscopic identification of CSF leaks using fluorescein in a low- to middle-income country setting like ours.
Human
;
Male
;
Adult (a Person 19-44 Years Of Age)
;
Skull Fracture, Basilar
;
Cranial Fossa, Posterior
9.Biomechanical taping and standard physical therapy were effective in the management of acute ankle inversion sprain: A pre- and post- intervention study.
Valentin Dones III ; Lyle Patrick Tangcuangco ; Mark Angel Serra ; Angeleah Abad ; Zacharie Fuentes ; Phyll Josh Labad ; Jannie Mauren Liboon ; Judy April Emmanuelle Miano ; Gian Karlo Reyes ; Marc Ryan Gerald Sabatin ; Maria Bianca Vergel de Dios
Philippine Journal of Allied Health Sciences 2020;3(2):9-17
BACKGROUND:
Ankle inversion sprain is a common musculoskeletal injury due to an inward foot twist. It results in pain, swelling, limited movement,
instability, and tenderness of the injured ankle. Standard physical therapy (PT) for acute ankle inversion sprain involves cryotherapy, range of
motion, balance, and strengthening exercises. Biomechanical Taping (BMT) is an adjunct to PT.
OBJECTIVES:
To identify the short-term effects of
BMT and PT on pain and function of individuals with acute ankle inversion sprains.
METHODS:
Two licensed physiotherapists screened the
participants. Eligible participants were treated 3x/week with BMT and PT, with a day of home exercises in between treatments. Participants
answered the Visual Analogue Scale (VAS) and Foot and Ankle Ability Measure (FAAM). Friedman Test was used to determine differences in prepost measurements of VAS and FAAM.
RESULTS:
17 participants (10 males: 7 females) with unilateral acute ankle inversion sprains were included
in the study with a mean (95% CI) age of 21 (20-22) years. BMT and PT (a) decreased VAS mean rank scores at Treatments 3 and 5 (p<0.05); (b)
improved FAAM-ADL mean rank scores in Treatments 1 and 3 (p<0.05); (c) improved FAAM-Sports mean rank scores in all Treatments (p<0.05);
and (d) improved in VAS, FAAM ADL and Sports scores between Treatment 1, Treatment 2 and Treatment 3 (p<0.00001).
CONCLUSION
BMT may
be an effective adjunct to PT in improving pain and function of participants with acute ankle inversion sprains. The increased stability created by
BMT may underpin the improved pain and function of participants.
Ankle Injuries
;
Fascia
;
Lateral Ligament, Ankle
;
Pain